A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation

As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV. SUPPLEMENTARY IN...

Descripción completa

Detalles Bibliográficos
Autores principales: Modjarrad, Kayvon, Moorthy, Vasee S, Ben Embarek, Peter, Van Kerkhove, Maria, Kim, Jerome, Kieny, Marie-Paule
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096003/
https://www.ncbi.nlm.nih.gov/pubmed/27387881
http://dx.doi.org/10.1038/nm.4131
Descripción
Sumario:As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nm.4131) contains supplementary material, which is available to authorized users.

Ejemplares similares